The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning
NCT04957407 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2021-07-12
Summary
Based on the gastric cancer database established earlier, this project explored the PG standard suitable for Chinese people, and further explored the establishment of machine learning model to stratify gastric cancer risk in the population, guide the frequency of gastroscopy screening, and extract important gastric cancer risk factors from it.Establish electronic health records of gastric organs, track the development and outcome of gastric diseases through deep learning method, in order to predict the development and outcome of gastric diseases;Then, the simulation hypothesis deductive method is used to compare the outcomes that may be caused by different lifestyles with the help of deep learning model, so as to guide patients to develop a better lifestyle and explore the establishment of health management paths for gastric cancer patients and high-risk groups in China.
Conditions
- Gastric Cancer
- Precancerous Lesion
- Mechine Learning
Interventions
- OTHER
-
pepsinogen
diagnostic value of pepsinogen for severe atrophy and gastric cancer
Sponsors & Collaborators
-
Second Affiliated Hospital, School of Medicine, Zhejiang University
lead OTHER
Principal Investigators
-
Yuling Tong, Dr. · 2nd affiliated hospital of Zhejiang University, school of medicine
Eligibility
- Min Age
- 25 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2022-05-31
- Completion
- 2022-12-31
Countries
- China
Study Locations
More Related Trials
-
Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer
NCT06478394 ·Status: RECRUITING
-
Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis
NCT06109805 ·Status: COMPLETED
-
Gastric Cancer Registry for Epidemiology and Molecular Risk Factor
NCT03046745 ·Status: UNKNOWN
-
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
NCT02674373 ·Status: UNKNOWN
-
A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer
NCT07096947 ·Status: COMPLETED
-
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
NCT02873520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer
NCT04850716 ·Status: UNKNOWN
-
Microbiota and Metabolomics of Intestinal Type of Gastric Cancer
NCT06079554 ·Status: RECRUITING
-
The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
NCT02150447 ·Status: TERMINATED ·Phase: PHASE3
-
A Multi-omics-based Metabolic Typing Study of Gastric Cancer
NCT06134011 ·Status: ACTIVE_NOT_RECRUITING
-
Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.
NCT03895008 ·Status: UNKNOWN
-
Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer
NCT01544413 ·Status: COMPLETED ·Phase: NA
-
Genomic and Dietary Aspects in Gastric Cancer Risk
NCT05934058 ·Status: NOT_YET_RECRUITING
-
Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study
NCT06814548 ·Status: NOT_YET_RECRUITING
-
Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer
NCT02327481 ·Status: COMPLETED ·Phase: NA
-
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
NCT05140746 ·Status: RECRUITING ·Phase: NA
-
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
NCT05497739 ·Status: UNKNOWN ·Phase: PHASE2
-
Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
NCT03632746 ·Status: UNKNOWN
-
Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway
NCT00498134 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method
NCT06100003 ·Status: RECRUITING
-
Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer
NCT02901301 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric Cancer
NCT01839500 ·Status: COMPLETED
-
Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer
NCT06305169 ·Status: NOT_YET_RECRUITING
-
Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies
NCT05648084 ·Status: COMPLETED
-
Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer
NCT02215837 ·Status: UNKNOWN ·Phase: PHASE2